Back to Results
First PageMeta Content
Pharmacology / Bisphosphonate / Alendronic acid / Osteoporosis / Osteonecrosis of the jaw / Zoledronic acid / Ibandronic acid / Risedronic acid / Aclasta / Bisphosphonates / Medicine / Chemistry


REGIONAL DRUG AND THERAPEUTICS CENTRE SAFER MEDICATION USE No. 2 January 2008
Add to Reading List

Document Date: 2011-03-21 15:19:23

Open Document

File Size: 114,25 KB

Share Result on Facebook

City

Newcastle upon Tyne / /

Company

Jamal SA / /

/

Facility

The National Institute / National Institute / /

/

IndustryTerm

treatment of osteoporosis / treatment of Paget’s disease / food / /

MedicalCondition

Osteonecrosis / cancer / multiple myeloma / GI disease / dysfunction / nausea / carcinoma / postmenopausal osteoporosis / bone disease / pain / Paget’s disease / post-menopausal osteoporosis / osteoporosis / Atrial fibrillation / renal dysfunction / influenza / oesophageal irritation / acute renal failure / /

MedicalTreatment

dental surgery / chemotherapy / surgery / /

Organization

National Institute for Health and Clinical Excellence / U.S. Food and Drug Administration / Regional Drug and Therapeutics Centre / FDA / Medicines and Healthcare products Regulatory Agency / NHS / National Institute for Health / /

Person

Ann Intern Med / Arch Intern Med / Mayo Clin Proc / Ann Pharmacother / /

/

Position

author / Governor / Miner / /

Product

Fosamax / REGIONAL DRUG AND THERAPEUTICS CENTRE SAFER MEDICATION / Didronel / Actonel / /

Technology

chemotherapy / http / /

URL

www.asbmr.org/images/pdf/AbstractBook2007.pdf / www.yellowcard.gov.uk / www.nyrdtc.nhs.uk / http /

SocialTag